Fresenius Medical Care AG (FMCQF)
OTCMKTS · Delayed Price · Currency is USD
51.06
-1.09 (-2.10%)
At close: Jul 29, 2025
ASLAN Pharmaceuticals Revenue
Fresenius Medical Care AG had revenue of 4.79B EUR in the quarter ending June 30, 2025, with 0.53% growth. This brings the company's revenue in the last twelve months to 19.52B, up 0.53% year-over-year. In the year 2024, Fresenius Medical Care AG had annual revenue of 19.34B, down -0.61%.
Revenue (ttm)
19.52B EUR
Revenue Growth
+0.53%
P/S Ratio
0.64
Revenue / Employee
175.03K EUR
Employees
111,513
Market Cap
14.62B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 19.34B | -117.71M | -0.61% |
Dec 31, 2023 | 19.45B | 55.60M | 0.29% |
Dec 31, 2022 | 19.40B | 1.78B | 10.10% |
Dec 31, 2021 | 17.62B | -240.38M | -1.35% |
Dec 31, 2020 | 17.86B | 382.51M | 2.19% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 84.04M |
Glass House Brands | 215.62M |
American Oncology Network | 1.76B |
Northwest Biotherapeutics | 1.47M |
Silence Therapeutics | 27.17M |
Global Cord Blood | 196.10M |
Fresenius Medical Care AG News
- 2 days ago - Fresenius Medical Care announces first tranche of its share buyback program of up to EUR 600 million as part of its new capital allocation framework - PRNewsWire
- 8 days ago - Fresenius Medical Care AG (FMS) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Fresenius Medical Care sees limited impact from tariffs, says CEO - CNBC
- 8 days ago - Fresenius Medical Care reports Q2 results - Seeking Alpha
- 8 days ago - Fresenius Medical Care delivers strong organic revenue growth and double-digit operating income growth in the second quarter of 2025 - PRNewsWire
- 22 days ago - Fresenius Medical Care: Is Trading Below Its Intrinsic Value (Buy) - Seeking Alpha
- 27 days ago - $6.3 Trillion Outpatient Clinics Markets, 2021-2024 & 2025-2029 | Profiles of Leading Players - Johns Hopkins Medicine, Mayo Clinic, MD Anderson Cancer Center, Apollo Hospital, and Fresenius Medical - GlobeNewsWire
- 5 weeks ago - Fresenius Medical in-pact with Coordination of National Institutes in Mexico - Seeking Alpha